March - 2019

NEWS

Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

Ymmunobio Appoints New Chief Operating Officer

Ymmunobio Accepted into Innosuisse Core Coaching

Dr. Katrin Rupalla Interviewed by Global Business Reports

Drug Discovery & Development

Fierce Biotech: Appointment of Michel Janicot

Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK ...

Authors: Iris Helfrich and Bernhard B. Singer Full Title: Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its...